Morgan Stanley earnings: 93 cents a share, vs 81 cents EPS expected

Andrew Cummings
October 17, 2017

Morgan Stanley now has an average rating of "Buy" and an average price target of $49.39. The firm has "Outperform" rating by Credit Suisse given on Monday, October 9.

07/20/2017 - Morgan Stanley had its "outperform" rating reiterated by analysts at BMO Capital Markets. Stifel Nicolaus maintained MEDNAX Inc (NYSE:MD) rating on Tuesday, November 3.

01/18/2017 - Morgan Stanley had its "buy" rating reiterated by analysts at UBS.

07/20/2017 - Morgan Stanley had its "outperform" rating reiterated by analysts at Macquarie. KeyBanc Capital Markets maintained the shares of BOJA in report on Monday, September 26 with "Overweight" rating.

01/11/2017 - Morgan Stanley had its "buy" rating reiterated by analysts at CLSA.

Cna Financial Corp decreased Morgan Stanley Com New (MS) stake by 13.43% reported in 2017Q2 SEC filing.

08/09/2017 - Wells Fargo began new coverage on Morgan Stanley giving the company a "market perform" rating. Over the last five trading sessions, the stock has moved -0.89%. Another is adding digital offerings - Morgan Stanley will roll out a robo adviser for smaller account balances this fall - without losing the loyalty of its 15,800 human brokers.

Revenue from stock-trading was essentially flat at $1.89 billion. The shares were sold at an average price of $46.68, for a total transaction of $1,202,803.56. Morgan Stanley (NYSE:MS) has risen 57.08% since October 17, 2016 and is uptrending. The company has market cap of $89.88 billion. Net interest income rose to $1 billion from $885 million previous year. It has a 12.94 P/E ratio. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management. This buyback authorization allows the financial services provider to reacquire up to 6.1% of its shares through open market purchases.

Analysts await MEDNAX Inc (NYSE:MD) to report earnings on October, 26.

Earnings applicable to common shareholders rose to $1.69 billion from $1.52 billion a year ago.

"Our third quarter results reflected the stability our wealth management, investment banking and investment management businesses bring when our Sales and Trading business faces a subdued environment", Chief Executive James Gorman said in a statement. Covering sell-side analysts are estimating company growth for next year to be 14.41%. Therefore 59% are positive. J P Morgan Chase & Co set a $53.00 price objective on Morgan Stanley and gave the company a "buy" rating in a research report on Friday, September 15th. The stock of Morgan Stanley (NYSE:MS) earned "Neutral" rating by Citigroup on Monday, October 9. Argus Research maintained the shares of MS in report on Tuesday, January 19 with "Buy" rating. Moreover, Morgan Stanley has 0.01% invested in Morgan Stanley (NYSE:MS). The stock of Morgan Stanley (NYSE:MS) has "Sell" rating given on Wednesday, January 13 by Societe Generale.

Other reports by iNewsToday